Related Experiment Videos
Alagille syndrome
1INSERM U347 and Départment de Pédiatrie, Hĵpital de Bicêtre, Le Kremlin-Bicêtre, France. hadchoue@kb.inserm.fr
Indian Journal of Pediatrics
|November 8, 2002
Summary
Alagille syndrome (AGS) is a genetic disorder affecting multiple organs. JAGGED1 gene mutations explain the diverse symptoms, suggesting a need to redefine AGS diagnostic criteria.
Area of Science:
- Genetics
- Pediatric Hepatology
- Developmental Biology
Background:
- Alagille syndrome (AGS) is a genetic disorder characterized by specific clinical features including liver, heart, and skeletal abnormalities.
- Despite a historically perceived good prognosis, AGS has a significant mortality rate, primarily due to complex congenital heart disease and hepatic complications.
Purpose of the Study:
- To investigate the role of the JAGGED1 gene in Alagille syndrome.
- To determine if JAGGED1 mutations explain the wide spectrum of AGS manifestations.
- To propose a re-evaluation of the current AGS definition based on genetic findings.
Main Methods:
- Identification of mutations in the JAGGED1 gene in patients diagnosed with Alagille syndrome.
- Analysis of JAGGED1 gene expression patterns.
- Correlation of genetic findings with the clinical features observed in AGS patients.
Main Results:
- Mutations in the JAGGED1 gene were identified as the cause of Alagille syndrome.
- JAGGED1 expression patterns correlate with the diverse clinical manifestations of AGS, indicating they are not coincidental.
- The genetic basis provided by JAGGED1 mutations explains the systemic nature of the syndrome.
Conclusions:
- JAGGED1 mutations are the underlying cause of Alagille syndrome.
- The genetic findings support a unified understanding of AGS, linking diverse symptoms to a single gene.
- The definition and diagnostic criteria for Alagille syndrome may require revision in light of JAGGED1 gene discoveries.